{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:39:28Z","timestamp":1786401568473,"version":"build-2736575974"},"reference-count":24,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Epidemiological data have provided limited and inconsistent evidence on the relationship between radiation exposure and lymphoid neoplasms. We classified 553 lymphoid neoplasm cases diagnosed between 1950 and 1994 in the Life Span Study cohort of atomic bomb survivors into World Health Organization subtypes. Mature B-cell neoplasms represented 58%, mature T-cell and natural killer (NK)-cell neoplasms 20%, precursor cell neoplasms 5%, and Hodgkin lymphoma (HL) 3%, with the remaining 15% classified as non-Hodgkin lymphoid (NHL) neoplasms or lymphoid neoplasms not otherwise specified. We used Poisson regression methods to assess the relationship between radiation exposure and the more common subtypes. As in earlier reports, a significant dose response for NHL neoplasms as a group was seen for males but not females. However, subtype analyses showed that radiation dose was strongly associated with increased precursor cell neoplasms rates, with an estimated excess relative risk per Gy of 16 (95% Confidence interval: 7.0, &amp;gt;533) at age 50. The current data based primarily of tissue-based diagnoses suggest that the association between radiation dose and lymphoid neoplasms as a group is largely driven by the radiation effect on precursor cell neoplasms while presenting no evidence of a radiation dose response for major categories of mature cell neoplasms, either B- or T-\/NK-cell, or more specific disease entities (diffuse large B-cell lymphoma, plasma cell myeloma, adult T-cell leukemia\/lymphoma) or HL.<\/jats:p>","DOI":"10.1182\/blood.2020010475","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T19:08:14Z","timestamp":1629832094000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Incidence of lymphoid neoplasms among atomic bomb survivors by histological subtype, 1950 to 1994"],"prefix":"10.1182","volume":"139","author":[{"given":"Megumu","family":"Fujihara","sequence":"first","affiliation":[{"name":"Department of Pathology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsu","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7001-0106","authenticated-orcid":false,"given":"Noriaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Clinical Studies, Radiation Effects Research Foundation, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-1383","authenticated-orcid":false,"given":"Kotaro","family":"Ozasa","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-2925","authenticated-orcid":false,"given":"Dale L.","family":"Preston","sequence":"additional","affiliation":[{"name":"Hirosoft International Corporation, Eureka, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-8777","authenticated-orcid":false,"given":"Kiyohiko","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2022011316244001800_B1","volume-title":"World Health Organization Classification of Tumours of Hematopoetic and Lymphoid TIssues.","author":"Jaffe","year":"2001"},{"key":"2022011316244001800_B2","first-page":"767","volume-title":"Cancer Epidemiology and Prevention","author":"Cerhan","year":"2017"},{"issue":"1","key":"2022011316244001800_B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood."},{"key":"2022011316244001800_B4","author":"UNSCEAR","year":"2008"},{"issue":"3","key":"2022011316244001800_B5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat Res."},{"issue":"3","key":"2022011316244001800_B6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1667\/RR2629.1","article-title":"Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases","volume":"177","author":"Ozasa","year":"2012","journal-title":"Radiat Res."},{"issue":"5","key":"2022011316244001800_B7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1667\/RR14492.1","article-title":"Solid cancer incidence among the life span study of atomic bomb survivors: 1958-2009","volume":"187","author":"Grant","year":"2017","journal-title":"Radiat Res."},{"key":"2022011316244001800_B8","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat Res."},{"issue":"2","key":"2022011316244001800_B9","first-page":"91","article-title":"Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia","volume":"18","author":"Matsuo","year":"1988","journal-title":"Jpn J Clin Oncol."},{"issue":"4","key":"2022011316244001800_B10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br J Haematol."},{"key":"2022011316244001800_B11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2307\/3578891","article-title":"Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies","volume":"137","author":"Mabuchi","year":"1994","journal-title":"Radiat Res."},{"key":"2022011316244001800_B12","volume-title":"WHO Classification of Tumours.","author":"Swerdlow","year":"2008"},{"key":"2022011316244001800_B13","author":"Sposto"},{"key":"2022011316244001800_B14","volume-title":"Epicure User Guide.","author":"Preston","year":"2015"},{"issue":"1","key":"2022011316244001800_B15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/HP.0000000000000598","article-title":"DS02R1: improvements to atomic bomb survivors\u2019 input data and implementation of dosimetry system 2002 (DS02) and resulting changes in estimated doses","volume":"112","author":"Cullings","year":"2017","journal-title":"Health Phys."},{"key":"2022011316244001800_B16","first-page":"129","volume-title":"Epidemiology of HTLV-I\/II in Japan and in the world. Advances in adult T-cell leuekemia and HTLV-I research.","author":"Tajima","year":"1992"},{"issue":"3","key":"2022011316244001800_B17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2307\/3578221","article-title":"Monoclonal gammopathy in atomic bomb survivors","volume":"133","author":"Neriishi","year":"1993","journal-title":"Radiat Res."},{"issue":"11","key":"2022011316244001800_B18","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1002\/cam4.1805","article-title":"Epidemiology and secular trends of malignant lymphoma in Japan: analysis of 9426 cases according to the World Health Organization classification","volume":"7","author":"Muto","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"2022011316244001800_B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09553000701616106","article-title":"Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors","volume":"84","author":"Kusunoki","year":"2008","journal-title":"Int J Radiat Biol."},{"issue":"5","key":"2022011316244001800_B20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1667\/0033-7587(2002)157[0493:UDONVA]2.0.CO;2","article-title":"Uneven distributions of na\u00efve and memory T cells in the CD4 and CD8 T-cell populations derived from a single stem cell in an atomic bomb survivor: implications for the origins of the memory T-cell pools in adulthood","volume":"157","author":"Kusunoki","year":"2002","journal-title":"Radiat Res."},{"issue":"7463","key":"2022011316244001800_B21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer [published correction appears in Nature. 2013;502(7470):258]","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature."},{"issue":"8","key":"2022011316244001800_B22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"2022011316244001800_B23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/asheducation-2009.1.353","article-title":"The role of NOTCH1 signaling in T-ALL","volume":"2009","author":"Ferrando","year":"2009","journal-title":"Hematology (Am Soc Hematol Educ Program)."},{"issue":"1","key":"2022011316244001800_B24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41379-020-0635-8","article-title":"A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia\/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1","volume":"34","author":"Takatori","year":"2021","journal-title":"Mod Pathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/2\/217\/1858812\/bloodbld2020010475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/2\/217\/1858812\/bloodbld2020010475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T16:41:21Z","timestamp":1642092081000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/2\/217\/476661\/Incidence-of-lymphoid-neoplasms-among-atomic-bomb"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020010475","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]}}}